These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23227847)

  • 21. Pro-oxidative/antioxidative imbalance: a key indicator of adverse outcome in hematopoietic stem cell transplantation.
    Yegin ZA; Paşaoğlu H; Aki SZ; Özkurt ZN; Demirtaş C; Yağci M; Acar K; Sucak GT
    Int J Lab Hematol; 2011 Aug; 33(4):414-23. PubMed ID: 21310008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia.
    Ghoti H; Goitein O; Koren A; Levin C; Kushnir T; Rachmilewitz E; Konen E
    Eur J Haematol; 2010 Jan; 84(1):59-63. PubMed ID: 19793250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
    Greenway A; Ware RE; Thornburg CD
    Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
    J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of aminothiols, nitrite, nitrate, and malondialdehyde in myelodysplastic syndromes in the context of clinical outcomes and as a consequence of iron overload.
    Pimková K; Chrastinová L; Suttnar J; Štikarová J; Kotlín R; Čermák J; Dyr JE
    Oxid Med Cell Longev; 2014; 2014():416028. PubMed ID: 24669287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatopulmonary syndrome associated with iron overload in sickle cell anaemia.
    Grinnan D; Herlihy A; Smith WR
    Eur Respir J; 2012 Jul; 40(1):275-6. PubMed ID: 22753840
    [No Abstract]   [Full Text] [Related]  

  • 27. Attenuation of serum ferritin and iron burden by intake of antioxidants in beta thalassemia major.
    Bhagat SS; Sarkar PD; Suryakar AN; Padalkar RK; Ghone RA; Patil SM; Hundekar PS
    Indian J Physiol Pharmacol; 2013; 57(2):189-94. PubMed ID: 24617170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions.
    Pack-Mabien A; Brown B; Herbert DE; Haynes J
    J Am Assoc Nurse Pract; 2015 Oct; 27(10):591-6. PubMed ID: 25711464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of βS allele in the lipid peroxidation and antioxidant capacity parameters.
    Shimauti EL; Belini Junior E; Baracioli LM; Souza EM; Granzotto D; Almeida EA; Silva DG; Ricci Junior O; Bonini-Domingos CR
    Int J Lab Hematol; 2014 Apr; 36(2):205-12. PubMed ID: 24118969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron in sickle-cell disease: what have we learned over the years?
    Inati A; Khoriaty E; Musallam KM
    Pediatr Blood Cancer; 2011 Feb; 56(2):182-90. PubMed ID: 21157888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron stores in adults with sickle cell anemia.
    Rao KR; Patel AR; McGinnis P; Patel MK
    J Lab Clin Med; 1984 May; 103(5):792-7. PubMed ID: 6715957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.
    Mangaonkar AA; Thawer F; Son J; Ajebo G; Xu H; Barrett NJ; Wells LG; Bowman L; Clair B; Patel N; Bora P; Jung G; Nemeth E; Kutlar A
    Br J Haematol; 2020 Jun; 189(6):1204-1209. PubMed ID: 32030737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron status and oxidative stress biomarkers in adults: a preliminary study.
    Mendes JF; Arruda SF; Siqueira EM; Ito MK; Silva EF
    Nutrition; 2009 Apr; 25(4):379-84. PubMed ID: 19056245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.
    Kalpatthi R; Peters B; Kane I; Holloman D; Rackoff E; Disco D; Jackson S; Laver JH; Abboud MR
    Pediatr Blood Cancer; 2010 Dec; 55(7):1338-42. PubMed ID: 20981690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of iron overload on renal functions and oxidative stress in beta thalassemia patients.
    Rasool M; Malik A; Jabbar U; Begum I; Qazi MH; Asif M; Naseer MI; Ansari SA; Jarullah J; Haque A; Jamal MS
    Saudi Med J; 2016 Nov; 37(11):1239-1242. PubMed ID: 27761563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.
    Wilson SR; Sears M; Williams E; Drapekin J; Sivakumar I; Padrino S; Desai PC; Hager W; Manwani D; Clay LJ; Field JJ; Kanter J; Cohen AJ; Saif Ur Rehman S; Lanzkron S; Little JA;
    Br J Haematol; 2021 Dec; 195(5):e157-e160. PubMed ID: 34423416
    [No Abstract]   [Full Text] [Related]  

  • 37. Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron deposition.
    Hankins JS; McCarville MB; Hillenbrand CM; Loeffler RB; Ware RE; Song R; Smeltzer MP; Joshi V
    Pediatr Blood Cancer; 2010 Sep; 55(3):495-500. PubMed ID: 20658621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload.
    Aygun B; Mortier NA; Kesler K; Lockhart A; Schultz WH; Cohen AR; Alvarez O; Rogers ZR; Kwiatkowski JL; Miller ST; Sylvestre P; Iyer R; Lane PA; Ware RE;
    Br J Haematol; 2015 Apr; 169(2):262-6. PubMed ID: 25612463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.
    Harmatz P; Butensky E; Quirolo K; Williams R; Ferrell L; Moyer T; Golden D; Neumayr L; Vichinsky E
    Blood; 2000 Jul; 96(1):76-9. PubMed ID: 10891433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron in sickle cell disease: a review why less is better.
    Koduri PR
    Am J Hematol; 2003 May; 73(1):59-63. PubMed ID: 12701123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.